Business Wire

DNP Develops Reflect Array to Expand 5G Coverage Area

Share

Dai Nippon Printing Co., Ltd. (DNP, TOKYO: 7912) has developed a Reflect Array that flexibly reflects the millimetre waves used in fifth generation (5G) mobile communications systems to expand coverage area.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210830005245/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Image of Reflect Array (Graphic: Business Wire)

Compared to general metal reflectors, the new product is capable of reflecting millimetre waves in a more targeted manner. As a result, there are fewer restrictions on installation, making it possible to improve the communications environment in locations where radio waves have been difficult to reach, such as those in the shadow of buildings. In addition, the new product boasts superior design features allowing it to respond to various installation environment considerations.

Background

The 24GHz and above radio waves used in the high-speed large-capacity communications of 5G are higher frequency milliwaves than those used in 4G, and maintain a larger information capacity. At the same time, they are characterized by strong straightness properties and short reach, leading to radio waves being blocked in areas such as in the shadow of buildings making it difficult to ensure communication quality. Also, when adding base stations and relay equipment to resolve this issue, new challenges emerge, such as large costs and the difficulty of securing installation space.

DNP has once again risen to the challenge, taken advantage of proprietary microfabrication technology, and by applying an original concept has successfully separated the Frequency Selection Reflection Layer that selectively reflects predetermined frequency bands while merely passing through other radio waves, and the Reflective Direction Control Layer, a special dielectric layer that decides the direction of incoming and reflected radio waves, to develop a Reflect Array that makes it easier to control for the characteristics of each layer. The newly developed product is cheaper than installing base stations and relay equipment, and does not require a power source. It can, therefore, be installed in a variety of location, which contributes to significant improvements in the 5G communications environment.

Features

  • Can be installed in a variety of locations

Unlike metal reflectors that reflect radio waves directly as in a mirror, the newly developed product is a reflective array capable of the asymmetric reflection of specific frequency radio waves. It is possible to flexibly set the frequency band to be reflected, the incidence angle of the radio waves received from the base station, and the reflection angle to deliver the radio waves, along with the spread of the reflection waves. As a result, it is now possible to effectively deliver radio waves to locations where it was previously difficult to do so. As a power source is no longer needed the new product can also be used in locations where installation space is restricted.

  • Effective designs based on original concepts

The new product is comprised of three layers: the Frequency Selective Surface Layer that selectively reflects predetermined frequency bands while merely passing through other radio waves, the Reflective Direction Control Layer that decides the direction of incoming and reflected radio waves, and a Design Cover Layer that not only protects these two layers, but also provides the durability required of construction materials along with high level design features that are conducive to various installation environment considerations.

  • Effective improvement of radio wave conditions

We have made it is possible to pre-adjust the spread of the reflection waves in answer to the desire to deliver reflection waves over a broad area, or to gather those waves into specific devices.

  • Reduces the impact on existing radio waves

Unlike metal reflectors that reflect all radio waves, the new product passes through all but target radio waves, reducing the impact on existing radio waves.

  • Superior design features

It is possible to print various patterns on the surface of the Design Cover Layer, making it possible to add external designs, including interior, exterior and advertising signboards.

Usage Scene

Recently, we have seen more companies and organizations consider the adoption of 5G as a means of targeting the realization of smart cities and smart factories that exploit robots and the Internet of Things (IoT). Commercialization efforts are already underway. With the development of the Reflect Array, we anticipate the following installation instances in cases where the radio wave environment is expected to deteriorate due to obstacles, and aim to link these initiatives to the spread of 5G.

  • Improvement of the communication environment behind radio wave shields in smart factories
  • Improvement of mobile device usage environment indoors at business offices and educational sites
  • Usage at exhibition spaces where layouts change with each event and radio wave shielding conditions alter
  • Usage at stadiums and amusement facilities where area-specific information is delivered
  • Applications leveraging design elements, such as urban buildings, walls and signboards that require harmony with the surrounding environment

Looking Ahead

DNP will work jointly with various communications-related companies, including communications carriers, to verify the functionality of the new product, aiming for commercialization from FY 2023.

The new product is a Passive type Reflect Array that fixes the reflection direction of the radio waves. We will engage in joint development of an Active type Reflect Array with multiple companies, and this research has been selected as a national project in FY2021.

About DNP

DNP is one of the world’s largest comprehensive printing companies, providing a diverse portfolio of products and services to about 20,000 corporate clients worldwide. Since we were founded in 1876, we have consistently innovated new products and processes, and have successfully integrated proprietary printing and information technologies to branch out into various fields, including packaging, decorative materials, display components, and electronic devices. DNP continues to take on the challenge of new business fields, including those related to the environment, energy, and life sciences. Our aim is to become a principal provider of solutions to a variety of problems by developing and combining new technologies.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media contact:
Mr. Yusuke Kitagawa, IR and Public Relations Division
TEL: +81-3-6735-0101
E-mail: kitagawa-y3@mail.dnp.co.jp

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

HCLTech Reports FY24 Revenue of $13.3 Billion, up 5.4% YoY26.4.2024 22:06:00 CEST | Press release

HCLTech, a leading global technology company, today reported financial results for the fourth quarter and the full year ended March 31, 2024. The company reported full year revenue of $13.3 billion, up 5.4% YoY. Digital Services revenue grew by 5.3% (CC) and now contributes to 37.3% of IT Services revenue. HCLSoftware’s Annual Recurring Revenue came in at $1.02 billion. During FY24, the company won 73 large deals – 36 in Services and 37 in Software - that translated into TCV (new deal wins) of $9.76 billion, up 10% YoY. For the quarter, revenue came in at $3.43 billion, up 6% YoY. HCLTech won 21 large deals – 13 in Services and eight in Software, with a TCV of $2.29 billion during the quarter. In terms of geographies, Americas was the fastest growing region with 6.8% YoY (CC) growth followed by Europe, which grew by 5.5% YoY (CC). Industry vertical growth was led by Financial Services and Telecommunications, Media, Publishing & Entertainment. While Financial Services grew at 12.1% YoY

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 18:03:00 CEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO ® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 17:43:00 CEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 17:22:00 CEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/Contact information Hawthorn Advisors suzano@hawthornadvisors.com

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 14:30:00 CEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye